Patel Chem Specialities Ltd

Patel Chem Specialities Ltd has announced a Board of Directors meeting scheduled for September 1, 2026. The meeting's agenda includes considering the re-appointment of Mrs. Anshu Bhupesh Patel, approving the Directors Report for FY26, and fixing the date, time, venue, and record date for the Annual General Meeting (AGM) for FY26. The board will also review the Secretarial Auditor's Report for FY25-26 and appoint a scrutinizer for the e-voting process at the AGM.

Patel Chem Specialities Ltd has issued a clarification regarding a reported deviation of ₹0.015 crore (₹1.50 lakh) in the utilization of IPO proceeds, as noted by the Monitoring Agency for Q1 FY27. The company states this is not a diversion of funds from the objects outlined in the Red Herring Prospectus (RHP). The shortfall occurred due to a premature closure of Fixed Deposits with Axis Bank, where the bank deducted a penalty without prior notice. Patel Chem assures that the amount will be replenished soon and utilized for the stated objects of the Issue. The company aims to address this minor discrepancy promptly to maintain transparency with its shareholders.

Patel Chem Specialities Ltd has submitted its Monitoring Agency Report for the June 2026 quarter, detailing the utilization of its IPO proceeds. The report, issued by Infomerics Valuation and Rating Limited, indicates a minor deviation of 0.025% of gross proceeds. A Rs 1.45 crore capex utilization in Q1FY27 left Rs 34.79 crore unutilized. However, the unutilized amount parked in fixed deposits and a monitoring account was Rs 34.78 crore, showing a shortfall of Rs 0.015 crore due to an interest penalty on premature FD closure. Management has committed to rectifying this shortfall in Q2FY27. The Monitoring Agency report is qualified to the extent of this shortfall.

Patel Chem Specialities Limited confirmed no deviation or variation in the use of proceeds from its Initial Public Offer (IPO) for the half-year ended March 31, 2026. The company raised ₹58.80 crores through its IPO on July 30, 2025. The statement, reviewed by the Audit Committee and taken on record by the Board of Directors on May 21, 2026, confirms adherence to the objects stated in the Prospectus. As of March 31, 2026, ₹16.27 crores have been utilized, with ₹36.24 crores remaining unutilized. Specifically, ₹6.90 crores were used for issue-related expenses, ₹8.40 crores for general corporate purposes, and ₹4.51 crores for capital expenditure. The unutilized capital expenditure funds are parked in a Fixed Deposit with Axis Bank.

Patel Chem Specialities Ltd has re-appointed M/s RTBR & ASSOCIATES, Company Secretaries, as their Secretarial Auditor for the financial year 2026-27. The re-appointment was approved by the Board of Directors on May 22, 2026, based on the recommendation of the Audit Committee, to comply with the Companies Act, 2013 and SEBI regulations.

Patel Chem Specialities Ltd has re-appointed M/s BIMAL SHAH ASSOCIATES, Chartered Accountants, as its Internal Auditor for the financial year 2026-27. The decision was made by the Board of Directors on May 22, 2026, based on the recommendation of the Audit Committee. This appointment is to comply with the Companies Act, 2013 and SEBI regulations.

Patel Chem Specialities Ltd has appointed M/s B R S & Associates as the Cost Auditor for the financial year 2026-27. The appointment was approved by the Board of Directors on May 22, 2026, based on the recommendation of the Audit Committee. The company has disclosed the details as per SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026, in Annexure-I.

Patel Chem Specialities Ltd's board approved the audited financial results for the half-year and year ended March 31, 2026, as per regulation 33 and 30 of SEBI guidelines. The board also approved the re-appointment of internal, secretarial, and cost auditors for FY 2026-2027. The auditor's report on the annual audited financial results for the year ended March 31, 2026, has an unmodified opinion.

The Board of Directors of Patel Chem Specialities Ltd approved the annual audited financial statements and results for the year ended March 31, 2026. They also approved the re-appointment of internal, secretarial, and cost auditors for FY 2026-2027. The board reviewed related party transactions and the utilization of IPO funds for the half-year ended March 31, 2026. The auditor's report on the financial results had an unmodified opinion.

Patel Chem Specialities Ltd has scheduled a Board of Directors meeting on May 22, 2026, to review and approve the annual audited financial statements and results for the year ended March 31, 2026. The board will also consider the re-appointment of internal, secretarial, and cost auditors for FY 2026-2027. The trading window is closed from April 1, 2026, and will reopen 48 hours after the declaration of the audited financial results.